Skip to Content
  • Review
  • Open Access

7 August 2024

20 Pages

A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies

,
,
,
,
,
,
,
,
…
1
Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Amman 11941, Jordan
2
Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London NW3 2QG, UK
3
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110608, India
4
Department of Nuclear Medicine, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar

Abstract

Non-tumorous kidney diseases include a variety of conditions affecting both the structure and function of the kidneys, thereby causing a range of health-related problems. Positron emission tomography/computed tomography (PET/CT) has emerged as a potential diagnostic tool, offering a multifaceted approach to evaluating non-tumorous kidney diseases. Its clinical significance extends beyond its conventional role in cancer imaging, enabling a comprehensive assessment of renal structure and function. This review explores the diverse applications of PET/CT imaging in the evaluation of non-cancerous kidney diseases. It examines PET/CT’s role in assessing acute kidney injuries, including acute pyelonephritis and other forms of nephritis, as well as chronic conditions such as immune complex-mediated glomerulonephritis and chronic kidney disease. Additionally, the review delves into PET/CT’s utility in evaluating complications in renal transplant recipients, identifying renal histiocytosis and detecting renal amyloidosis. The current review aims to promote further research and technological advancements to popularize PET/CT’s clinical utility in diagnosing and treating non-tumorous kidney diseases.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.